Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2011 May;117(5):1105-1113.
doi: 10.1097/AOG.0b013e31821188ad.

Continuation and satisfaction of reversible contraception

Jeffrey F Peipert  1 , Qiuhong Zhao, Jenifer E Allsworth, Emiko Petrosky, Tessa Madden, David Eisenberg, Gina Secura
Affiliations
Clinical Trial

Continuation and satisfaction of reversible contraception

Jeffrey F Peipert et al. Obstet Gynecol. 2011 May.

Abstract

Objective: To estimate 12-month satisfaction and continuation rates of intrauterine device (IUD) and implant users enrolled in the Contraceptive CHOICE Project and compare these measures with women using the oral contraceptive pills (OCPs).

Methods: We analyzed 12-month data from the first 5,087 participants enrolled in a prospective cohort study of women in the St. Louis region offered contraception at no cost for 3 years. The primary purpose of CHOICE is to promote the use of long-acting reversible contraception (IUDs and implants) and to reduce unintended pregnancies in our region. This analysis includes those participants who received their baseline contraceptive method within 3 months of enrollment and who reached the 12-month follow-up telephone survey time point (n=4,167).

Results: Sixty-eight percent of our participants chose a long-acting reversible contraception method (45% levonorgestrel intrauterine system, 10% copper IUD, and 13% subdermal implant), 23% chose combined hormonal methods (11% OCPs, 10% vaginal ring, and 2% transdermal patch), and 8% chose depot medroxyprogesterone acetate. Long-acting reversible contraception users had higher 12-month continuation rates (86%) than OCP users (55%). The two IUDs had the highest 12-month continuation rates: levonorgestrel intrauterine system (88%) and copper IUD (84%). Women using the implant also had very high rates of continuation at 1 year (83%). Satisfaction mirrored continuation: more than 80% of users were satisfied with the IUD compared with 54% satisfied with OCPs.

Conclusion: IUDs and the subdermal implant have the highest rates of satisfaction and 12-month continuation. Given that long-acting reversible contraception methods have the highest contraceptive efficacy, these methods should be the first-line contraceptive methods offered to patients.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Kaplan Meier survival curve estimating continuation rates for long-acting reversible contraception (LARC) compared with non–long-acting reversible contraception methods.
See this image and copyright information in PMC

References

    1. Mosher WD, Jones J. Use of Contraception in the United States: 1982–2008. National Center for Health Statistics. Vital Health Statistics. 2010:23. - PubMed
    1. Gilliam ML, Neustadt A, Kozloski M, Mistretta S, Tilmon S, Godfrey E. Adherence and acceptability of the contraceptive ring compared with the pill among students: a randomized controlled trial. Obstetrics & Gynecology. 2010;115:503–510. - PubMed
    1. Rosenberg MJ, Waugh MS. Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons. Am J Obstet Gynecol. 1998;179:577–582. - PubMed
    1. Picardo C, Ferreri S. Pharmacist-administered subcutaneous depot medroxyprogesterone acetate: a pilot randomized controlled trial. Contraception. 2010;82:160–167. - PubMed
    1. Sangi-Haghpeykar H, et al. Experiences of injectable contraceptive users in an urban setting. Obstet Gynecol. 1996;88(2):227–333. - PubMed

Publication types

Substances